ArticleJournal of gastroenterology2022

Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy.

Dag Holmberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.